Archive for June, 2011


FDA Recall Alerts: McNeil Consumer Healthcare Announces Voluntary Recall Oe One Product Lot Of TYLENO® Extra Strength Caplets 225 Count Distributed In The U.S.

Fort Washington, PA – McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is recalling at the retail level one product lot (60,912 bottles) of TYLENOL®, Extra Strength Caplets, 225 count bottles, distributed in the U.S. The recalled product was manufactured in February, 2009. McNeil is taking this action following a small number of odor reports, including [...]

Read More...

FDA Mediation Watch: Tylenol Extra Strength Caplets, 225 count bottles: Recall – Uncharacteristic Odor

One lot recalled due to the presence of trace amounts of a 2,4,6-tribromoanisole (TBA), which has been associated with temporary and non-serious gastrointestinal symptoms. MedWatch Safety Alert RSS Feed

Read More...

FDA Mediation Watch: Tylenol Extra Strength Caplets, 225 count bottles: Recall – Uncharacteristic Odor

One lot recalled due to the presence of trace amounts of a 2,4,6-tribromoanisole (TBA), which has been associated with temporary and non-serious gastrointestinal symptoms. MedWatch Safety Alert RSS Feed

Read More...

FDA Press Releases: FDA: New York dietary supplement manufacturer enters into consent decree

The U.S. Food and Drug Administration has announced that Howard Sousa, doing business as the Artery Health Institute LLC, and DeSousa LLC, in New York, N.Y., has signed a consent decree of permanent injunction. The consent decree prohibits Sousa from distributing products with claims in the labeling to cure, treat, mitigate or prevent diseases. Food [...]

Read More...

FDA New Drugs Feed: Breakdown of FDAAA Completed Pediatric Studies

(updated) What’s New: Drugs RSS Feed

Read More...